GFM
DFTX

GF Fund Management’s Definium Therapeutics DFTX Stock Holding History

GF Fund Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.3K Sell
2,111
-102
-5% -$2.52K ﹤0.01% 333
2026
Q1 		$41.8K Buy
2,213
+278
+14% +$4.72K ﹤0.01% 418
2025
Q4 		$25.9K Buy
1,935
+298
+18% +$3.69K ﹤0.01% 479
2025
Q3 		$19.3K Sell
1,637
-240
-13% -$2.24K ﹤0.01% 492
2025
Q2 		$12.2K Hold
1,877
– – ﹤0.01% 544
2025
Q1 		$11K Buy
1,877
+337
+22% +$2.41K ﹤0.01% 555
2024
Q4 		$10.7K Buy
+1,540
New +$10.6K ﹤0.01% 534

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

GF Fund Management's DFTX Position: Q2 2026 in Review

GF Fund Management reduced its Definium Therapeutics (DFTX) stake by 4.6% in Q2 2026, selling an estimated $2.52K and leaving 2,111 shares worth $99.3K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

GF Fund Management first reported a position in DFTX in Q4 2024 and has held it in 7 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • GF Fund Management held 2,111 shares of Definium Therapeutics worth $99.3K as of Q2 2026.
  • GF Fund Management sold 102 Definium Therapeutics shares in Q2 2026, an estimated $2.52K.
  • Definium Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #333 holding.
  • GF Fund Management first reported a position in Definium Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.